6-Methyl-1-(pyrimidin-2-yl)-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one

Catalog No. :
ACUTXJ916
CAS No. :
1156608-54-6
Molecular Formula :
C10H8N6O
Molecular Weight :
228.21

IUPAC Name:6-methyl-1-(pyrimidin-2-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one

6-Methyl-1-(pyrimidin-2-yl)-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$253.00Login to see priceInquiryInquiry
100mg95%$369.00Login to see priceInquiryInquiry
250mg95%$520.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Methyl-1-(pyrimidin-2-yl)-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one
IUPAC Name6-methyl-1-(pyrimidin-2-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one
MDL No.MFCD12427457
Molecular FormulaC10H8N6O
Molecular Weight228.21
SMILESO=C1C2=C(N(C3=NC=CC=N3)N=C2)N=C(C)N1
InChI KeyWMVLFSBZXDDNTC-UHFFFAOYSA-N
Synonym6-methyl-1-(pyrimidin-2-yl)-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one;4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,5-dihydro-6-methyl-1-(2-pyrimidinyl)-
CAS No.1156608-54-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACUTXJ916 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGNPY406 route compound structure diagram
    ACGNPY40630129-57-8 In Stock
  2. Plus
  3. ACNKTZ369 route compound structure diagram
    ACNKTZ3691722-12-9 In Stock
  4. Then
  5. ACUTXJ916 route product structure diagram
    ACUTXJ9161156608-54-6
Inquiry

2. ACUTXJ916 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUTXJ916 route product structure diagram
    ACUTXJ9161156608-54-6
Inquiry

Comments (0)